Ledger.Open graph →
SEC Form D · filed November 23, 2009

Kylin Therapeutics Inc

Offering
$2.0M
Sold
$58K
Exemption
—
Industry
Biotechnology
Location
West Lafayette, IN
Type
—

People & firms on this filing (6)

Lindsey Schwartz · Bellevue, WAExec · DirectorJoseph Trebley · West Lafayette, INExecThomas M. Gainor · Charleston, SCExec · DirectorChristopher Meldrum · Durham, NCExec · DirectorJoseph Trebley · Indianapolis, INExecHomer Pearce · West Lafayette, INDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗